san francisco semaglutide weight loss Medical GLP-1 Replying to @Bridget my weight

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial Summary: This Phase 1b trial assessed the safety, tolerability, pharmacokinetics, and pharmacodynamics of co-administering once-weekly subcutaneous cagrilintide (at various doses) with semaglutide 2.4 mg in participants for weight management

Embody ($199/mo month-to-month or $149/mo on a 12-month plan, flat)

This is the same mechanism that makes GLP-1 agonists like semaglutide effective for weight management

Neuroscience and Behavioral Physiology, 38(9), 953957

This approach targets fat loss through multiple mechanisms without relying on appetite suppression

10.1016/j.toxlet.2011.05.933 72 PestkaJ